New funding from Innovate UK’s latest Biomedical Catalyst Call is now available to boost healthcare and life science technology company R&D.
£30 million grant funding is available to UK medtech, health and life science SMEs for early and late stage projects. The projects need to be 12-36 months in length with total project costs between £250,000 and £4M.
With funding of up to 70% of the total project costs available, each project must be SME led.
Don’t delay! The deadline for applications is 11am, 7th October 2020.
The competition is open to any UK health & life science company that has a project that meets a specific
health and care need. Well-being and wellness products are also eligible to apply.
Innovate UK reports that projects that are able to provide supporting evidence regarding target users / customers are likely to score higher during the written assessment and be able to present a clearer justification for funding to the major awards committee. If you are planning to apply and require market size intelligence or have any other market research requirement, please contact us without delay.
To find out more, visit Innovate UK: https://www.gov.uk/guidance/biomedical-catalyst-what-it-is-and-how-to-apply-for-funding
Philippa Bevan has over 25 years commercial and public sector experience in marketing, market research and product management spanning the education, laboratory, medical device, technology transfer and packaging industries. Philippa has a BSc (Hons) in Microbiology and Virology and is a Chartered Marketer.
